More than 90% of people with Down syndrome develop Alzheimer disease but receive little or no treatment for their dementia. Novel biomarkers of ageing and dementia bring new hope to this medically vulnerable population and can also help researchers understand dementia in other populations.

中文翻译：

---

生物标志物显示研究唐氏综合症痴呆的价值

超过 90% 的唐氏综合症患者会患上阿尔茨海默病，但他们很少或根本没有接受痴呆症治疗。衰老和痴呆症的新型生物标志物为这一医学弱势群体带来了新的希望，也可以帮助研究人员了解其他人群的痴呆症。